• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Politicsabortion

U.S. states buying millions of doses of medication abortion drugs amid fears that courts could make them illegal

By
Steve LeBlanc
Steve LeBlanc
and
The Associated Press
The Associated Press
Down Arrow Button Icon
By
Steve LeBlanc
Steve LeBlanc
and
The Associated Press
The Associated Press
Down Arrow Button Icon
April 11, 2023, 6:10 AM ET
Massachusetts Governor Maura Healey
Massachusetts has purchased enough doses of the drug mifepristone — one of two drugs used in combination to end pregnancies — to last for more than a year, Democratic Gov. Maura Healey saidJessica Rinaldi—The Boston Globe/Getty Images

A growing number of states led by Democratic governors are stockpiling doses of drugs used in medication abortions, amid fears that a court ruling could restrict access to the most commonly used method of abortion in the U.S.

Massachusetts has purchased enough doses of the drug mifepristone — one of two drugs used in combination to end pregnancies — to last for more than a year, Democratic Gov. Maura Healey said Monday. California has secured an emergency stockpile of up to 2 million pills of misoprostol, the other drug used in abortion medication, Gov. Newsom, also a Democrat, announced.

And in Washington state, Democratic Gov. Jay Inslee announced last week that the state purchased 30,000 doses of the generic version of mifepristone — which he said is enough to last the state’s residents three years. The shipment arrived in late March.

“Abortion is still legal and accessible here in California and we won’t stand by as fundamental freedoms are stripped away,” Newsom said Friday.

The actions come as U.S. District Judge Matthew Kacsmaryk, a Trump appointee in Amarillo, Texas, overruled decades of scientific approval Friday and put on hold federal approval of mifepristone.

The judge stayed his ruling for a week so federal authorities could file a challenge.

The Biden administration slammed the ruling and on Monday appealed the decision, saying it would thwart the U.S. Food and Drug administration’s scientific judgment and “severely harm women, particularly those for whom mifepristone is a medical or practical necessity.”

Adding to the confusion was a second opinion also released on Friday by District Judge Thomas O. Rice, an Obama appointee, directing U.S. authorities not to make any changes that would restrict access to the drug in at least 17 states where Democrats sued in an effort to protect availability.

Healey said the Kacsmaryk ruling threatens access to the medication even in states supportive of abortion rights like Massachusetts.

“It harms patients, undermines medical expertise, and takes away freedom. It’s an attempt to punish, to shame, to marginalize women. It’s unnecessary,” Healey said, surrounded by fellow Democratic lawmakers including U.S. Sen. Elizabeth Warren on the steps of the Massachusetts Statehouse.

“It is terrible. It is terrible,” she added.

Newsom said the ruling by Kacsmaryk “ignores facts, science, and the law,” and puts the health of millions of women and girls at risk.

Inslee said it’s important for states to take steps to ensure access to the drug.

“After we announced our actions last week to protect access to mifepristone, it’s heartening to see other states doing the same,” Inslee wrote on Twitter on Monday. “To be clear: no matter the outcome of the TX case, WA’s laws ensure we will be able to sell and distribute this medication.”

The 15,000 doses in Massachusetts were purchased by the University of Massachusetts-Amherst at Healey’s request.

Massachusetts health care providers have also agreed to buy additional quantities of mifepristone, according to Healey, who said the administration is dedicating $1 million to help providers contracted with the Department of Public Health to pay for the doses.

While there are no plans yet in Connecticut to stockpile mifepristone, Attorney General William Tong said Monday that he has been contacting major pharmacy chains to remind them the drug is legal and they should not be influenced by pressure from GOP attorneys general in other states.

”(I’m) obviously deeply disappointed that my colleagues have taken that action,” he said. “We’re pushing back on that. We’re in communication with all the big pharmacy chains, advising them of their rights and obligations here in Connecticut.”

Also on Friday, Healey signed an executive order expanding a 2022 law meant to build a legal firewall around abortion services — protecting health care providers, patients and pharmacists from out-of-state investigations into medication abortions. The law was signed after the U.S. Supreme Court ruling overturning Roe v. Wade.

The Fortune 500 Innovation Forum will convene Fortune 500 executives, U.S. policy officials, top founders, and thought leaders to help define what’s next for the American economy, Nov. 16-17 in Detroit. Apply here.
About the Authors
By Steve LeBlanc
See full bioRight Arrow Button Icon
By The Associated Press
See full bioRight Arrow Button Icon

Latest in Politics

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Politics

Jack Schlossberg
PoliticsElections
Jack Schlossberg on why Democrats lost young men to Trump—and it starts with the reason he quit the Biden campaign
By Nick LichtenbergMarch 19, 2026
12 hours ago
Elon Musk, wearing a DOGE shirt and hat, puts one hand to the brim of the hat as he stands in the Oval Office.
LawDOGE
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents show
By Sasha RogelbergMarch 19, 2026
12 hours ago
EconomySocial Security
Social Security has 6 years left. The fix that sounds cruelest may be the smartest
By Nick LichtenbergMarch 19, 2026
12 hours ago
pete hegseth
EconomyIran
The Pentagon reportedly requested an extra $200 billion for the Iran war. It might fund the U.S. military for just 140 more days
By Jake AngeloMarch 19, 2026
13 hours ago
A podium with a sign reading "save healthcare" stands in front of the U.S. Capitol building.
Healthaffordability
‘Sometimes I don’t even take my medicine’: Americans are choosing between insulin and buying gas following Trump’s ACA cuts
By Ali Swenson and The Associated PressMarch 19, 2026
14 hours ago
jones
Energygas
Meet the Jones Act, the law that has made gas more expensive for Americans for decades
By Christopher Niezrecki and The ConversationMarch 19, 2026
14 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.